ResearcherSpanish National Cancer Research CentreNo recent work listed

Carolina Navas

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5072543794. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper

Papers 2

EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.ccr.2012.08.001 ↗
Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. Co-author DOI 10.1016/j.ccr.2011.05.011 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Alberto J. Schuhmacher · 2 shared papers, 2011–2012 · strength 0.06
- Paper EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccr.2012.08.001 ↗
- Paper Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. DOI 10.1016/j.ccr.2011.05.011 ↗
Mariano Barbacid · 2 shared papers, 2011–2012 · strength 0.06
- Paper EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccr.2012.08.001 ↗
- Paper Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. DOI 10.1016/j.ccr.2011.05.011 ↗
Carmen E. Guerra · 2 shared papers, 2011–2012 · strength 0.06
- Paper EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma. DOI 10.1016/j.ccr.2012.08.001 ↗
- Paper Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. DOI 10.1016/j.ccr.2011.05.011 ↗
Manuel Collado · 1 shared paper, 2011 · strength 0.03
- Paper Pancreatitis-induced inflammation contributes to pancreatic cancer by inhibiting oncogene-induced senescence. DOI 10.1016/j.ccr.2011.05.011 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.